The answer to your question is correct, but the question is not.
Cynata does not manufacture/derive/sell induced pluripotent stem cells (iPSC). They obtain the starting material from FCDI (licensing agreement) as starting material for their iPSC-derived MSCs (Cymerus process). In other words, is Coca Cola the leader in carbonated water?
How many companies do you know of that have completed recruitment for a P3 trial using an iPSC-derived therapy?
How many companies do you know of that have completed a P1 trial using iPSC-derived MSCs? Have they conducted any P2 trials using an iPSC-derived therapy? If so, have they commenced a P3 trial using an iPSC-derived therapy?
The answer to your question is correct, but the question is...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $42.48M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.5¢ | $940 | 3.999K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17622 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 58959 | 2 |
View Market Depth
| Last trade - 10.02am 14/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |